## Variants and diseases

### [Relational list using ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/)

|Disease|Gene|Variants|
|-------|----|--------|
|Hemochromatosis|HJV|NM_213653.3:c.959G>T|
|Thalassemia|	HBB	|NM_000518.5(HBB):c.*113A>G|
|Haemophilia|	F8	|NM_000132.3(F8):c.1804C>T (p.Arg602Ter)	|
|Cystic Fibrosis| CFTR		|NM_000492.4(CFTR):c.2658-2A>G	|
|Tay sachs disease| HEXA	|NM_000520.6(HEXA):c.1385A>T (p.Glu462Val)	|
|Fragile X syndrome|FMR1	|NM_002024.5(FMR1):c.52-1_52delinsTA	|
|Huntington's disease|HTT	|NM_002111.8(HTT):c.52CAG[(36_39)]	|


### [Relational list using ClinGen](https://clinicalgenome.org/)
|Gene|Gene name|Chromosomal location|Gene product|Disease|
|----|---------|--------------------|------------|-------|
|CFTR|CF transmembrane conductance regulator|7q31.2|epithelial ion channel, transport of chloride ions across the cell membrane|Cystic fibrosis|
|CYBB|	cytochrome b-245 beta chain|Xp21.1-p11.4| Critical component of the membrane-bound oxidase of phagocytes that generates superoxide|granulomatous disease |
|HJV|hemojuvelin BMP co-receptor|1q21.1	|Acts as a bone morphogenetic protein (BMP) coreceptor|hemochromatosis type 2A|
|CDKN2A|cyclin dependent kinase inhibitor 2A|9p21.3|Negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6|melanoma-pancreatic cancer syndrome|
|KRAS|KRAS proto-oncogene, GTPase|12p12.1|Ras proteins bind GDP/GTP and possess intrinsic GTPase activity|Noonan syndrome|
|TP53|tumor protein p53|17p13.1|Acts as a tumor suppressor in many tumor types|Li-Fraumeni syndrome 1|
|FMR1|FMRP translational regulator 1|Xq27.3|Multifunctional polyribosome-associated RNA-binding protein|Fragile X syndrome|
